CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elbendary, A.
Right arrow Articles by Marks, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elbendary, A.
Right arrow Articles by Marks, J. R.

Cell Growth & Differentiation, Vol 5, Issue 12 1301-1307, Copyright © 1994 by American Association of Cancer Research


ARTICLES

Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells

A Elbendary, A Berchuck, P Davis, L Havrilesky, RC Bast Jr, JD Iglehart and JR Marks
Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina 27710.

Transforming growth factor beta (TGF beta) is an important regulator of cellular proliferation. In normal ovarian epithelial cells, TGF beta acts to inhibit growth. However, in ovarian cancer cell lines, this effect is usually lost. Although the regulatory pathway of TGF beta remains unclear, TGF beta-treated cells arrest late in G1. This inhibition appears to involve blocking of the cyclin-dependent kinase phosphorylation of the retinoblastoma protein. Recently, a general inhibitor of cyclin-dependent kinases, CIP1/WAF1/p21, was identified. Expression of CIP1 is positively regulated by binding of wild-type p53 to a consensus response element upstream of the CIP1 gene. Overexpression of the CIP1 protein causes growth suppression, analogous to TGF beta and wild-type p53. We have examined the induction of CIP1 by TGF beta 1 in ovarian cancer cell lines that have been previously characterized for their proliferative response to TGF beta 1. OVCA420, a cell line that is dramatically growth inhibited by TGF beta 1, significantly induced CIP1 expression in response to TGF beta 1. CIP1 induction was accompanied by a decrease in cdk2 kinase activity and cdk2 protein levels. In three other cell lines that respond weakly to TGF beta 1, CIP1 expression was not induced. To determine if TGF beta 1 induction occurs via p53, regulation of p53 RNA and protein was examined. No differences in p53 transcription, steady-state protein level, de novo synthesis, phosphorylation, or subcellular accumulation were noted. Furthermore, TGF beta 1 could not induce transcription from a consensus p53 DNA binding site in the TGF beta 1-response cell line.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
L. D. Osborne, G. Z. Li, T. How, E. T. O'Brien, G. C. Blobe, R. Superfine, and K. Mythreye
TGF-{beta} regulates LARG and GEF-H1 during EMT to affect stiffening response to force and cell invasion
Mol. Biol. Cell, November 5, 2014; 25(22): 3528 - 3540.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
K. E. Lambert, H. Huang, K. Mythreye, and G. C. Blobe
The type III transforming growth factor-{beta} receptor inhibits proliferation, migration, and adhesion in human myeloma cells
Mol. Biol. Cell, May 1, 2011; 22(9): 1463 - 1472.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. W. Young, D. G. Rosen, F. C. Mei, N. Li, J. Liu, X.-F. Wang, and X. Cheng
Up-regulation of Tumor Susceptibility Gene 101 Conveys Poor Prognosis through Suppression of p21 Expression in Ovarian Cancer
Clin. Cancer Res., July 1, 2007; 13(13): 3848 - 3854.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. A. Siegenthaler and M. W. Miller
Transforming Growth Factor {beta}1 Promotes Cell Cycle Exit through the Cyclin-Dependent Kinase Inhibitor p21 in the Developing Cerebral Cortex
J. Neurosci., September 21, 2005; 25(38): 8627 - 8636.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
J. Wang, N. Sergina, T. C. Ko, J. Gong, and M. G. Brattain
Autocrine and Exogenous Transforming Growth Factor {beta} Control Cell Cycle Inhibition through Pathways with Different Sensitivity
J. Biol. Chem., September 17, 2004; 279(38): 40237 - 40244.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Khanna
Concerted effect of transforming growth factor-{beta}, cyclin inhibitor p21, and c-myc on smooth muscle cell proliferation
Am J Physiol Heart Circ Physiol, February 6, 2004; 286(3): H1133 - H1140.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
R. A. Gupta, P. Sarraf, J. A. Brockman, S. B. Shappell, L. A. Raftery, T. M. Willson, and R. N. DuBois
Peroxisome Proliferator-activated Receptor {gamma} and Transforming Growth Factor-{beta} Pathways Inhibit Intestinal Epithelial Cell Growth by Regulating Levels of TSC-22
J. Biol. Chem., February 28, 2003; 278(9): 7431 - 7438.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. M. Duplan, Y. Theoret, and R. Kenigsberg
Antitumor Activity of Fibroblast Growth Factors (FGFs) for Medulloblastoma May Correlate with FGF Receptor Expression and Tumor Variant
Clin. Cancer Res., January 1, 2002; 8(1): 246 - 257.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Cheng, H. Shen, N. Rodrigues, S. Stier, and D. T. Scadden
Transforming growth factor beta 1 mediates cell-cycle arrest of primitive hematopoietic cells independent of p21Cip1/Waf1 or p27Kip1
Blood, December 15, 2001; 98(13): 3643 - 3649.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C.-R. Chen, Y. Kang, and J. Massague
Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor {beta} growth arrest program
PNAS, January 30, 2001; 98(3): 992 - 999.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. J. Shankland and G. Wolf
Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis
Am J Physiol Renal Physiol, April 1, 2000; 278(4): F515 - F529.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Baekelandt, R. Holm, C. G. Trope, J. M. Nesland, and G. B. Kristensen
Lack of Independent Prognostic Significance of p21 and p27 Expression in Advanced Ovarian Cancer: An Immunohistochemical Study
Clin. Cancer Res., October 1, 1999; 5(10): 2848 - 2853.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Drissi, D. Hushka, F. Aslam, Q. Nguyen, E. Buffone, A. Koff, A. J. van Wijnen, J. B. Lian, J. L. Stein, and G. S. Stein
The Cell Cycle Regulator p27kip1 Contributes to Growth and Differentiation of Osteoblasts
Cancer Res., August 1, 1999; 59(15): 3705 - 3711.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
F. DOCAGNE, O. NICOLE, H. H. MARTI, E. T. MacKENZIE, A. BUISSON, and D. VIVIEN
Transforming growth factor-{beta}1 as a regulator of the serpins/t-PA axis in cerebral ischemia
FASEB J, August 1, 1999; 13(11): 1315 - 1324.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
G. S. Hagopian, G. B. Mills, A. R. Khokhar, R. C. Bast Jr., and Z. H. Siddik
Expression of p53 in Cisplatin-resistant Ovarian Cancer Cell Lines: Modulation with the Novel Platinum Analogue (1R, 2R-Diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV)
Clin. Cancer Res., March 1, 1999; 5(3): 655 - 663.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Iavarone and J. Massague
E2F and Histone Deacetylase Mediate Transforming Growth Factor beta  Repression of cdc25A during Keratinocyte Cell Cycle Arrest
Mol. Cell. Biol., January 1, 1999; 19(1): 916 - 922.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. A. Steinman, J. Huang, B. Yaroslavskiy, J. P. Goff, E. D. Ball, and A. Nguyen
Regulation of p21(WAF1) Expression During Normal Myeloid Differentiation
Blood, June 15, 1998; 91(12): 4531 - 4542.
[Abstract] [Full Text] [PDF]


Home page
EMBO J.Home page
S. Dennler, S. Itoh, D. Vivien, P. ten Dijke, S. Huet, and J.-M. Gauthier
Direct binding of Smad3 and Smad4 to critical TGF{beta}-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene
EMBO J., June 1, 1998; 17(11): 3091 - 3100.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
A. Pedram, M. Razandi, R.-M. Hu, and E. R. Levin
Astrocyte Progression from G1 to S Phase of the Cell Cycle Depends upon Multiple Protein Interaction
J. Biol. Chem., May 29, 1998; 273(22): 13966 - 13972.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. Tong, H. L. Grimes, T.-Y. Yang, S. E. Bear, Z. Qin, K. Du, W. S. El-Deiry, and P. N. Tsichlis
The Gfi-1B Proto-Oncoprotein Represses p21WAF1 and Inhibits Myeloid Cell Differentiation
Mol. Cell. Biol., May 1, 1998; 18(5): 2462 - 2473.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
H. H. Cha, E. J. Cram, E. C. Wang, A. J. Huang, H. G. Kasler, and G. L. Firestone
Glucocorticoids Stimulate p21 Gene Expression by Targeting Multiple Transcriptional Elements within a Steroid Responsive Region of the p21waf1/cip1 Promoter in Rat Hepatoma Cells
J. Biol. Chem., January 23, 1998; 273(4): 1998 - 2007.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
W. Poluha, C. M. Schonhoff, K. S. Harrington, M. B. Lachyankar, N. E. Crosbie, D. A. Bulseco, and A. H. Ross
A Novel, Nerve Growth Factor-activated Pathway Involving Nitric Oxide, p53, and p21WAF1 Regulates Neuronal Differentiation of PC12 Cells
J. Biol. Chem., September 19, 1997; 272(38): 24002 - 24007.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
H Wu, M Wade, L Krall, J Grisham, Y Xiong, and T Van Dyke
Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration.
Genes & Dev., February 1, 1996; 10(3): 245 - 260.
[Abstract] [PDF]


Home page
J Biol ChemHome page
J. R. Biggs, J. E. Kudlow, and A. S. Kraft
The Role of the Transcription Factor Sp1 in Regulating the Expression of the WAF1/CIP1 Gene in U937 Leukemic Cells
J. Biol. Chem., January 12, 1996; 271(2): 901 - 906.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
J DeGregori, G Leone, K Ohtani, A Miron, and J R Nevins
E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity.
Genes & Dev., December 1, 1995; 9(23): 2873 - 2887.
[Abstract] [PDF]


Home page
Genes Dev.Home page
I Reynisdottir, K Polyak, A Iavarone, and J Massague
Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
Genes & Dev., August 1, 1995; 9(15): 1831 - 1845.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1994 by the American Association of Cancer Research.